chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, burning/itching skin, lethargy, back/head/neck pain, 99.6F temperature.
I received the vaccination approximately 945am, 19 Mar 2021. I started to experience full body itching side-effects between noon and 1330, 20 Mar 2021. I have not altered any eating habits nor have I taken any over-the-counter drugs until about 15 minutes ago.
Fever, Fatigue, and pain in the left arm but it was worst with the 2nd shot and the booster.; Worst Fever after 2nd shot/Worst Fever after first Monovalent Booster Shot; Worst Fatigue after2nd shot/Worst Fatigue after first Monovalent Booster Shot; Worst Pain in the left arm after 2nd shot/Worst Pain in the left arm after first Monovalent Booster Shot; This spontaneous case was reported by a patient and describes the occurrence of CONDITION AGGRAVATED (Fever, Fatigue, and pain in the left arm but it was worst with the 2nd shot and the booster.), PYREXIA (Worst Fever after 2nd shot/Worst Fever after first Monovalent Booster Shot), FATIGUE (Worst Fatigue after2nd shot/Worst Fatigue after first Monovalent Booster Shot) and VACCINATION SITE PAIN (Worst Pain in the left arm after 2nd shot/Worst Pain in the left arm after first Monovalent Booster Shot) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONDITION AGGRAVATED (Fever, Fatigue, and pain in the left arm but it was worst with the 2nd shot and the booster.), PYREXIA (Worst Fever after 2nd shot/Worst Fever after first Monovalent Booster Shot), FATIGUE (Worst Fatigue after2nd shot/Worst Fatigue after first Monovalent Booster Shot) and VACCINATION SITE PAIN (Worst Pain in the left arm after 2nd shot/Worst Pain in the left arm after first Monovalent Booster Shot). In 2020, VACCINATION SITE PAIN (Worst Pain in the left arm after 2nd shot/Worst Pain in the left arm after first Monovalent Booster Shot) outcome was unknown. At the time of the report, CONDITION AGGRAVATED (Fever, Fatigue, and pain in the left arm but it was worst with the 2nd shot and the booster.), PYREXIA (Worst Fever after 2nd shot/Worst Fever after first Monovalent Booster Shot) and FATIGUE (Worst Fatigue after2nd shot/Worst Fatigue after first Monovalent Booster Shot) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-661795.   Reporter did not allow further contact
The second 0.2ml dose in the series of Pfizer pediatric was given 13 days after the patient turned 12 years old.
She presented  to the ER on 2/13 with a lot of chest pain and had some flattening of her T waves.  She ended up getting a cardiac catheterization while she was there which was normal.   The day prior to this she had actually received her second Covid vaccination in her left arm.  She noticed achiness and soreness across her shoulders bilaterally into her chest and into her neck.  She had some subjective fevers and chills and felt generally fatigued.  She also had a lot of swelling in her left axilla and she ended up getting a CT scan during her workup which revealed some left axillary adenopathy.  She returned to the ER on 3/16: while brushing her teeth, she developed right facial paresthesias that marched over approximately 20 minutes to involve the right arm and the right leg.  She went to the hospital.  She was seen in the ER.  They felt this represented possible ischemia.  They gave her tPA.  She had a hemorrhagic nosebleed.  Did not develop any other signs of bleeding. Her symptoms had not resolved.  She was discharged from home.  She had a headache at the time of her visit to the ER.  Her headache had resolved by the time she was discharged home, but she continues to note paresthesias in the right side of her body, right face, and notes over the last day or 2, she has had increased dysarthria, dizziness and slurred speech, brain fog, a sensation of heaviness and inability to think.  She states she currently does not have head pain per se, but she does note that she just feels generally poorly.  She feels like her brain is working faster than her mouth muscles are.  She is in today for neurologic followup, concerned about these ongoing issues.  she continues to struggle with her speech feeling quite slow and deliberate, she feels like it is difficult for her to concentrate, she is forgetful, she still has intermittent episodes of paresthesias in her face, arm, and hand, she feels like she becomes heart and flushed and she has some heart rate variability with her heart going slow and fast, and she has significant disequilibrium.  She is extremely fatigued where she is only able to get up for 1-2 hours before she is extremely fatigued and has to go back to bed.
Discomfort at the site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Discomfort at the site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy (Allergy to Pollen), Food allergy (Allergy to Pine tart) and Allergy to animal (Allergy to Cat).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE DISCOMFORT (Discomfort at the site). At the time of the report, VACCINATION SITE DISCOMFORT (Discomfort at the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included Allergy injection as patient reported its intake twice a month for past 20-30 years. Concomitant medication included vitamins. Treatment information were not provided.   This case was linked to MOD-2021-242526 (Patient Link).
Case previously recorded as MA2009-4552. Initial case report received from a nurse via agency, on 18 NOV 2009. A 72-week-old patient was accidentally vaccinated with 0.5 mL of FLUVIRIN 2009/2010 intramuscular (batch no. 102126P1A) on 17 NOV 2009. No adverse events was reported. Company assessment: Seriousness criterion: not serious. Causality: not applicable. Expectedness assessment according to foreign/local agency: No change in benefit-risk-ratio. No measures necessary. Agency reference no.: NA09-008426.
Swelling of whole of thigh after single dose of DTaP, happened after first dose also; parents did not want any vaccines, convinced them to get it.
Headache; Arm soreness; Mild body aches; Light headedness/ got dizzy easily; Thirst; Got dizzy easily; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 01Apr2021 at 09:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. No concomitant medications were taken by the patient. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 01Apr2021 at 13:00 the patient experienced headache, arm soreness, mild body aches, light headedness, got dizzy easily and thirst. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, arm soreness, mild body aches, light headedness, got dizzy easily and thirst were recovered on an unspecified date in Apr-2021.   No follow-up attempts are needed. No further information is expected.
Arm was hurting; Bad injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of   in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and HYDRALAZINE HYDROCHLORIDE (DIAZIDE [HYDRALAZINE HYDROCHLORIDE]) for an unknown indication.   On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.
Pt broke out in an allergic reaction all over her body on 7/12/01. She developed itching. Pt is not known to have any medication allergies.
5-6 hrs p/vax extreme vomiting, h/a 2 days;
DTAP to left shoulder.  Shoulder red and swollen and warm after 24-48 hours.
Feeling sick/ill, under the weather.; Achey in ears; Tingling in ears; stuffy; Nasal congestion; tired; headache; This is a spontaneous report from a contactable healthcare professional. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EP7533), via intramuscular route of administration in the left arm on 01April2021 at 13:15 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient previously received doxycycline (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Concomitant medication included harmone intrauterine device (MANUFACTURER UNKNOWN) within two weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination.  On 03April2021 at 00:00, the patient experienced feeling sick or ill, under the weather, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic and emergency room or department or urgent care. The clinical outcome of the events feeling sick or ill, achey, tingling in ears, stuffy, nasal congestion, tiredness and headache was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Within hour of first injection, Myocarditis reaction, diarhea for days, EXTREME headaches and vagus nerve pain and feeling like I was having an allergic reaction that would not clear up.   Still ongoing; brain fog, general malaise, chronic fatigue, vagus nerve issues, gut issues, still feel flu like and it has been months since i had both vaccine shots.  I feel like I'm having an extreme auto immune inflammatory response that no one can help me with.  Prior to this we could not pinpoint my exact auto immune disease (except lyme and co infections) but I had gotten it into a "remission like state."  Prior to the vaccine I was symptom free.  Everything has gotten worse again since the vaccine.  Difficult to work, do daily functions etc.  Also a large lymph node on back right of neck that has not bothered me since childhood was enlarged for weeks but that has gotten better.
Approximately 1040 a - vaccine administered to (L) deltoid. Upon check out, became light headed and dizzy. Pale and gray in color. Brought pt to room, lay down, HR 78 BP 82/48 at 1100. Dizzy, 1130 pt sat elevated BP 90/60. Ate crackers and drank ginger ale while in office. Walked up/down hallway - no dizziness RTO on 11/4 with headache, dizzy.
Information has been received from a licensed practitioner nurse concerning a 72 year old female patient, with no pertinent medical history and no drug reactions or allergies, who on 05-NOV-2010 was vaccinated with a dose of ZOSTAVAX (Merck) (lot # 664628/1018Y, expire date 16-JAN-2011), intramuscularly. On 05-NOV-2010, while the patient was still at the office, she developed a "3 centimeter round circle of redness that was painful at the site." There were no laboratory diagnostics studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Started feeling hot, redness all over body and itching that lasted 24 hours.  Bilateral neck itching/redness and hives remain. Still occurring 1 week after vaccine. Worse at night.
The morning following my second vaccine, I woke up with my face, eyes, lips and throat completely swollen. One week later my heart condition (SVT) became uncontrollable/more severe. My skin on my face became extremely dry and peeling for weeks. I was pregnant and had a miscarriage one month later.
Information has been received from a 31 year old female patient for the pregnancy Registry for VARIVAX. Some time in February, 2007 was vaccinated with VARIVAX (Lot and route not reported). Concomitant therapy included vitamins (manufacturer unspecified). And about two weeks later after receiving VARIVAX the patient found out she was pregnant (2007). The patient reported that before receiving VARIVAX she just finished nursering her first child. On 07-NOV-2008 she had her child and her child is healthy. The patient sought medical attention. Additional information has been requested. Follow up information was received from the questionnaire which indicated that the patient was 30 year old female who had one previous pregnancy and full term delivery. In 2006 the patient was treated for varicella antibodies and the result was negative. On 01-FEB-2007 the patient was vaccinated a dose of VARIVAX. Concomitant therapy included prenatal vitamins. The patient's last menstrual period was 10-FEB-2007. On 07-NOV-2007, the patient delivered a normal male baby whose weight was 8 pounds and 4 ounce. It was reported that there were no congenital anomalies or other abnormalities with the infant and no complications during pregnancy, labor/delivery, or illnesses/infections during pregnancy. In approximately 2008 the patient developed acne and was treated with Bactrim, Spironolactone and Azithromycin. At the time of this report, the outcome of acne was unknown.
I started getting symptoms of sore throat. The next day I was fatigued and had a fever. I took a COVID-19 at home that was positive. I contacted my doctor and I took a PCR test that was positive. I received a prescription for PAXLOVID but can only take 1 due to a renal condition that I take medication for. My symptoms did progress to diarrhea and a cough. These symptoms lasted until yesterday and today I am still coughing.
Patient received booster 1 month after primary; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received booster 1 month after primary) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M21A, 083J21A and 083J21A) for COVID-19 vaccination.     Patient did not have allergies to medications, food and other products.    On 06-Apr-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 03-May-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 03-Jun-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 03-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received booster 1 month after primary). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received booster 1 month after primary) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was not taking other medication. It was reported that Patient did not report having side effects. The expiration dates were not provided. Patient HCP is unaware patient received the 1st booster a month after primary. No treatment information reported.
Patient has a history of occasional nose bleeds, however after receiving 2nd Moderna vaccine he is experiencing nose bleeds every other day lasting >20 minutes.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 15 years old adolescent patient and unknown gender. On 11-SEP-2014 the patient was vaccinated with a dose of an improperly stored GARDASIL (lot J015378, expiration date 09-APR-2016) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported was unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.
both parents said started crying yesterday AM at 8M & cried cont-high pitched cry until around 1 or 2PM yesterday PM;site was only sl puff w/no redness;
lip & face swelling; lip & face swelling; This is a spontaneous report from a Contactable consumer. This consumer reported for Female patient.   A 14-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date(at the age of 14 years old) as 2nd dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunisation and patient had no reaction on previous exposure to Vaccine. On an unspecified date, the patient experienced lip and face swelling 7 days post second dose of Pfizer COVID-19. Event was occurred after use of product. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Case number PHEH2013US015178, is an initial spontaneous report received from a pharmacist on 15 Jul 2013: This case refers to a 17 years old female patient. She was vaccinated with expired MENVEO (batch number: M10047 and expiry date: Dec 2012) intramuscularly on 12 Jul 2013. No adverse reaction was reported following this administration error.
redness, swelling, hardness, immed p/vax; it was reported that pt recv vax & exp redness, swelling & hardness @ inj site;MD is treating sx ice & zyrtec & elocon cream;
Diffuse palpable purpuric rash, followed by acute kidney injury with gross hematuria and proteinuria
Tightness, in chest, pale, warm, nauseated.  Cold packs were applied, she denied any difficulties breathing and recovered completely within a few minutes.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Sometime in June 2013 the patient was vaccinated with ZOSTAVAX (lot #, expiration, route unspecified) at the right arm. In 2013 the patient had two hospitalizations for shortness of breath and neuropathy on the right side of (her) body after being administered ZOSTAVAX. The demographics for the hospital where the patient was admitted were unknown. The length of time that the patient spent in the hospital for both admissions were also unknown. At the time of report, the events outcome were unknown. Additional information has been requested.
Extreme pain in vaccinated arm, from shoulder to fingertips.   On 8/19/2010 patient awoke at 7:15 AM with crushing chest pain and jaw pain.  Went to ER.
pt recv vax & pt who did not seroconvert p/vax w/3 doses of measles vax;
Numbness in right side of head and right arm (where he received injection). Starting getting confused. Legs started to give out. Continued working. Symptoms got worse. On and off paralysis of legs. Eyes flickered and darted. When he sat down at 1am, he took two nitroglycerin for chest pain. He asked a nurse to take his blood pressure. It was low. He felt he was losing control. He was struggling for breath. Eyes were tearing up real bad and tremors started. He stated he fought to stay conscious. Was started on oxygen. Was assisted in a wheelchair and taken to ER. Waited there for 4 hours. Was delusional. I left without being seen by a doctor after blood work and EKG. Went to sleep and woke up in river of sweat. Went to urgent care at that time. Was given a COVID test and it was negative. Was prescribed zinc and vitamins. He had the same symptoms like he did when he originally got COVID. Today at 9:36am, have fever off and on. Continues to feel pretty bad. Still dizzy.
lt arm became reddened & swollen;sx started about 2hr p/vax;
Moderna COVID-19 Vaccine EUA:   Beginning 05/14/21:  Ongoing Extreme fatigue, complete loss of appetite, >10% weight loss over 4-week period. 5/16/21: Severe mast cell reaction 05/16/21 -- treated with IV Benadryl, IV famotidine, oral Ativan.  5/17/21: Leg pain 5/18/ 21: Nausea 5/22/21:  Large joint pain; treated with topical compound cream (ketoprofen, ketamine, lidocaine, cyclobenzaprine) 5/26/21: Tachycardia 130 bpm; shortness of breath (S.O.B.); Week of 6/2/21:  Full body tenderness (flu-like);  6/8/21:  Major headache -- treated with 30mg IV Toradol (+ IV Zofran); consulted PCP; 6/9/21:  ONGOING Joint paint (hips, knees, elbows, wrists); Gait disruption begins.  No longer able to walk 10 meters. 6/10/21: Burning pain in heels, large left toe joint swelling, right forearm swelling; 6/11-12/ 21:  Leg/ foot pain continues--  treated with IV Toradol (+ IV Zofran); 6/12/21 to PRESENT:  began ongoing but intermittent electric shock-like pain in feet; radiating sciatic pain; headaches Level 7; tachycardia; adrenaline rushes; Hot flashes; Coat hangar pain. 6/17/21 PCP prescribed Norco 5mg;  Takes maximum of 1/2 tab b.i.d.; 6/21/21:  Consult with cardiologist; 6/23/21:  Decadron burst 8mg 5 days; begin taper and return to 8mg 3 more days;  Begin taper dosage 7/3/21; neuropathy not relieved, appetite increased. 6/29/21:  Gabapentin -- reacted with severe headache, discontinued; 7/2/21:   Began extreme blood pooling in feet (dark purple) 7/5/21:  Hot burning feet; begin to have pain when extending arms or leaning forward more than 30 degrees. 7/6/21:  No longer perceives hot water on feet; Resurgence of hyperhidrosis in hands & armpits;  ongoing. 7/9/21:  intermittent numbness on left shin;  ongoing major joint pain; continued electrical shock-like pain in feet.  Gait disruption continues.  Progressive neuropathy.   V Now unable to ambulate 10 Meters without walker assistance or wheelchair.
I had a sore arm for 3 days after receiving my booster in addition to a mild headache that lasted until the next day. Months later, I started having a bronchial cough that wouldn't go away; the cough worsened and caused some congestion. I took an at-home rapid antigen COVID-19 test on 07/01/2022, but that one came back negative. However, the next morning, the cough became worse so I took another at-home test on 07/02/2022 that came back positive. I called my doctor who prescribed me PAXLOVID. That evening, I took my first dose and will finish my last of the 5-day treatment tomorrow. As of now with the medication, I have a slight cough and feeling better but not as great as I was before contracting COVID-19.